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Abstract: We report the preparation of a non-polymer coated superparamagnetic nanoparticle 
that is stable and biocompatible both in vitro and in vivo. The non-polymer, betaine, is a natural 
methylating agent in mammalian liver with active surface property. Upon systemic adminis-
tration, the nanoparticle has preferential biodistribution in mammalian liver and exhibits good 
reduction of relaxivity time and negative enhancement for the detection of hepatoma nodules 
in rats using MRI. Our data demonstrate that the non-polymer coated superparamagnetic 
nanoparticle should have potential applications in biomedicine.
Keywords: SPIO nanoparticle, betaine, hepatoma, MRI
Introduction
The applications of superparamagnetic iron oxide nanoparticles (SPIO) in biomedicine have 
been actively pursued in recent years (Wilkinson 2003; Gupta and Gupta 2005; Hu 
and Yu 2006). However, relatively little work has been carried out on the non-polymer 
coated superparamagnetic nanoparticles with entire size smaller than 10 nm. It has 
been demonstrated that the size of iron oxide particle and the coating have a notable 
inﬂ  uence on its magnetic property, cellular uptake and cell viability. Generally speak-
ing, the nanoparticles employed for in vivo applications should be sufﬁ  ciently small, 
stable at physiological condition without aggregation and present superparamagnetic 
behavior at room temperature. All SPIO nanoparticles presently undergoing preclinical 
or clinical testing are coated with polymeric material (eg, dextran, carboxydextran, 
polyethylene glycol). Dextran limits the tolerance of the compound, which can there-
fore only be administered as a slow infusion (Panyam and Labhasetwar 2003). In 
fact, all polymers used, even the well-tolerated polyethylene glycol, have limitations 
in tissue distribution, penetration, metabolic clearance and produce adverse reactions 
(Zhang et al 2002).
Recently, a non-polymer (citrate) coated superparamagnetic nanoparticle has been 
investigated in MR angiography (Schnorr et al 2002; Taupitz et al 2000; Wagner 
et al 2002). Here we report a non-polymer coated SPIO nanoparticle, which has an 
overall size around 9 nm and is stable and biocompatible both in vitro and in vivo. 
Following systemic administration, the nanoparticle has preferential biodistribution in 
mammalian liver and exhibits good reduction of relaxivity time and negative enhance-
ment for the detection of hepatoma nodules in a rat model using magnetic resonance 
imaging (MRI).
The surface chemistry of nanoparticles is important for their potential applications 
in biomedicine. In this report, we use betaine as a stabilizing agent for the preparation 
of SPIO nanoparticles. We choose betaine for this purpose based on the following con-
siderations: (1) betaine is a molecule comprising amphiphilic character, which is stable 
over a wide pH range in biological conditions; (2) betaine is a natural methylating agent 
in mammalian liver, which has been found to protect the livers of experimental animals International Journal of Nanomedicine 2007:2(4) 806
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against the hepatotoxic ethanol and carbon tetrachloride; and 
(3) betaine is an effective hydrotrope with small size, which 
possesses well-tolerated in tissue penetration and metabolic 
clearance in vivo (Barak et al 1996). The aim of this study is 
to generate betaine coated SPIO nanoparticle and investigate 
its potential applications in vivo. Our preliminary data dem-
onstrate that the non-polymer coated nanoparticle is useful 
as an MRI contrast agent.
Methods and results
Preparation and characterization of SPIO 
nanoparticles
For the preparation of magnetite nanoparticles, 1 M 
FeCl3.6H2O (>99%) was mixed with 2 M FeCl2.4H2O 
(>99%) at the ratio 2:1 and then 28.6% (w/w) Betaine 
hydrochloride (Fluka Biochemika) was dissolved in the 
solution by stirring. The pH of reaction solution was adjusted 
with the 3M NaOH until reaching a pH value of 11. After 
stirring vigorously for 15 min, the solution pH was adjusted 
to 4 by adding 2M HCl dropwise. The betaine coated Fe3O4 
particles were collected by magnetic separation by applying 
a permanent magnet for 30 min and washed with deionized 
water three times. To remove excess ions and betaine fur-
ther, the product was dialyzed against with deionized water 
overnight. Following this, the solution was centrifuged at 
3500 g at RT for 10 min. Finally the product was passed 
though a 0.22 μm ﬁ  lter and used for investigations. Electron 
micrographs of the magnetite dispersions were carried out 
using a drop of the sample onto a copper mesh coated with 
an amorphous carbon ﬁ  lm. This mesh was then dried in a 
vacuum desiccator. TEM images were performed using a 
type JEOL-JEM-100-CXΙΙ with working condition 100 kV. 
Figure 1a shows a TEM image of the iron oxide suspensions 
with a well-dispersed feature.
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Figure 1 Characterization of the SPIO nanoparticle. (a) TEM image of the SPIO nanoparticles from the as-synthesized colloidal suspensions following centrifugation at 
10,000 rpm, Bar 50 nm, magniﬁ  cation 20,000×, (b) X-ray powder diffraction patterns of the SPIO nanoparticles, (c) FT-IR spectrum of the SPIO nanoparticles, and (d) 
chemical structure of betaine (above) and the proposed electrostatic interaction of the betaine with Fe3O4 (below).International Journal of Nanomedicine 2007:2(4) 807
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To characterize the products further, partial products 
were dried in vacuum oven at 25 °C for 12 h and used for 
X-ray diffraction (XRD) analysis (Taupitz et al 2002). 
XRD data were collected on a Rigaku D/max 2550 V X-ray 
diffractometer employing Cu-Ka radiation (λ = 1.54056 
A at 40 kV and 100 mA). Figure 1b displays the XRD 
patterns for the as-precipitated powders corresponding 
to Figure 1a. As magnetite (Fe3O4) may be converted to 
maghemite (gamma Fe2O3) in the presence of oxygen, it 
is possible that the core of the resulting nanoparticles can 
consist of maghemite as it has been demonstrated recently 
(Thünemann et al 2006).
The surface properties were characterized using FT-IR. 
The iron oxide precipitates were dried and ground with KBr 
for IR measurements by a Nexus 670 FT-IR spectropho-
tometer with a resolution of 2 cm−1. FT-IR analysis was 
performed to characterize the surface nature of the resulting 
magnetite nanoparticles, as depicted in Figure 1c. A vibra-
tional feature at 1628 cm−1 is found and assigned to the C–N 
stretching motion, which could be derived from betaine that 
was coated on Fe3O4. The broad peak appeared in the region 
3200–3600 cm−1 region corresponds to the O–H stretching 
vibration as the iron oxide surfaces are readily covered with 
hydroxyl groups in an aqueous environment (Cheng et al 
2005). The proposed electrostatic interaction of the betaine 
with Fe3O4 was shown in a scheme in Figure 1d.
To investigate the magnetic properties of the SPIO 
nanoparticle, magnetization measurements have been made 
at 23 °C with respect to the particle size using a vibrating 
sample magnetometer (VSM, JDM-13) at –18000 Oe  H 
 18000 Oe. The superparamagnetic behavior of the SPIO 
nanoparticle was evidenced by zero coercivity and remanence 
on the magnetization loop and a saturation magnetization 
of 56.8 emu/g was determined (Figure 2a). The Fe3O4 con-
centrations were measured by treating the iron oxides with 
nitric acid and were calculated on the basis of the average 
diameter of the iron oxide particles. Moreover, a 0.3T NMR 
spectrometer with an extremity 5 cm coil was used for the r1; 
r2 measurement of SPIO nanoparticles in the water. The T1 
and T2 measurements were carried out using the inversion 
recovery and Carr-Purcell-Meiboom-Gill (CPMG) sequences, 
respectively. Samples were dissolved into deionized water 
and were analyzed for subsequent determination of the r1 and 
r2 properties. The commercial Gd-DTPA was also analyzed 
for a comparative study. At a concentration of 0.1 mM of the 
magnetite particles, the longitudinal relaxation time (T1) was 
reduced from 2117 ms for pure water to 408 ms (Figure 2b), 
while the T2 relaxation time was reduced from 2039 to 108 
ms (Figure 2c). A comparison of T1 and T2 values of ddH2O, 
Gd-DTPA and SPIO that were measured using each pulse for 
refocusing in the multiecho sequence is given in Table 1. Our 
data demonstrated that the SPIO nanoparticle strongly reduced 
both T1 and T2 relaxation times with T2 signiﬁ  cantly lower 
than T1. Therefore, this particle may have the potential for MR 
imaging as a contrast agent.
Cytotoxicity evaluation
Cell lines including SMMC-7721 and HL7702 were cultured 
in DME medium supplemented with 10% fetal bovine serum, 
2 mm l-glutamine and 50 mg/ml gentamicin at 3 × 104 cells/
well in 24-well plates at 37 °C under a humidiﬁ  ed atmosphere 
of 95% air and 5% CO2. After 24 h, the cells were applied 
with serial 5-fold dilutions of the SPIO nanoparticle and 
Gd-DTPA (Schering AG, Germany) in triplicate with ﬁ  nal 
concentrations ranging from 0.2 to 5 mM for 4 h. Following 
replenishment with fresh medium, the cells were incubated 
for addition 48 h. Histochemistry analysis was carried out 
with Prussian blue staining for the presence of iron. Figure 4a 
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Figure 2 Magnetic properties of the SPIO nanoparticle. The magnetic hyster-
esis loops of the particle were measured at room temperature and a saturation 
magnetization of 56.8 emu/g was determined (a). Both r1 and r2 of the SPIO 
nanoparticle (0.1 mM in the water at 23 °C) were evaluated by a 0.3 T MR imager. 
The longitudinal relaxation time (T1) was reduced from 2117 ms for pure water 
to 408 ms (b), while the T2 relaxation time was reduced from 2039 to 108 ms (c). 
Inversion-recovery was prepared with a variety of inversion time from 10 to 5000 
ms and the CPMG spin echo with a variety of echo time from TE = 10–400 ms.International Journal of Nanomedicine 2007:2(4) 808
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shows the viabilities of both SMMC-7721 and HL7702 cells 
exposed to the ferroﬂ  uids at various iron concentrations. Cell 
viability was determined by using the 5-dimethylthiazol-
2-yl-2, 5-diphenyl tetrazolium bromide (MTT) assay. The 
cells used for this purpose were ﬁ  xed with 3% formaldehyde 
and washed with PBS, followed by the incubation with 2% 
potassium ferrocyanide in 6% hydrochloric acid for 30 min. 
After wash, the cells were counterstained with Giemsa solu-
tion. The viability of the cells was expressed as the mean ± 
S.E. of the percentage of absorbance of controls where 100% 
equaled viability of untreated control cells. Prussian blue 
staining of the transfected cells showed the uptaking of 
the SPIO nanoparticles in the cytoplasm (b) and no stain-
ing was observed in the cytoplasm of the cells transfected 
with Gd-DTPA (c) and the no-transfected SMMC-7721 
(d). In addition, the SPIO nanoparticles were administrated 
into the Wistar rats via lateral tail vein at a dose 10mg/kg 
for hemolysis assay (Weissleder et al 1990). The number 
and morphology of blood cells were evaluated 24 h latter 
(e and f) and the feedback of the rats in the following 3 
months was examined. These data strongly suggested that 
the SPIO nanoparticle would be generally considered to be 
biocompatible.
Magnetic resonance imaging
Animals were purchased from Shanghai SLAC laboratory 
animal Co. LTD and a hepatoma model of rat was developed 
with DEN as described elsewhere (Mathew et al 1980; Wil-
liams et al 1996). MRI examinations were performed on 
a 1.5 T GE tweenspeed MR imager using a commercially 
available extremity 7.6 cm coil.
To evaluate the potential of the SPIO nanoparticle in 
clinical MR imaging further, the signal intensity alterations 
inﬂ  uenced by interactions between nanoparticles and water 
or whole blood were analyzed using different imaging 
sequences. Serial 10-fold dilutions of the SPIO nanopar-
ticles were prepared in the deionized water and human 
whole blood to the ﬁ  nal concentrations, ranging from 10−2 
to 10−7 M. The same concentration gradients of Gd-DTPA 
were also prepared for comparative observation. 1.5 ml of 
each preparation was loaded into an array of 1.5 ml Eppen-
dorf tubes in a plastic rack. The image was taken using the
designed sequences by 3 acquisitions with the ﬁ  eld of view 
being 80 × 80 mm2. The parameters for T1 image was spin 
echo (SE) with repetition time (TR) 460 ms, echo time (TE) 
9.0 ms in a matrix size of 512 × 512, for T2 image was fast 
spin echo (FSE) with TR/TE = 3000 ms/70.1 ms, echo train 
length (ET) = 17 ms in a matrix size of 256 × 256 and for 
T2 weighted image was gradient echo with TR/TE/ﬂ  ip 
angle = 340 ms/17ms/ 30 in a matrix size of 512 × 512. The 
signal intensity of each sample was determined by standard 
region-of-interest measurements of cross sectional image of 
each individual tube using the provided image quantiﬁ  ca-
tion tool. In Figure 4, the representative images from T1 
(a), T2 (b) and T2W (c) revealed that MR signal intensity 
was affected by the ion concentrations of the two contrast 
agents. The dispersion of the SPIO nanoparticle in an array 
of concentration gradient of human whole blood ranged 
from 10−2 to 10−5 M iron concentration showed signiﬁ  cant 
decreasing of signal intensity at 10−3 M (d), especially 
in T2 weighted MR image. In vitro MR images of SPIO 
nanoparticles were highly consistent with the results of r1 
and r2 measurements described above.
For the application of the SPIO nanoparticle to detect 
hepatoma nodules, the rats were anesthetized for MR imaging 
by means of intramuscular injection of 50 mg/kg ketamine 
hydrochloride and the contrast medium was injected into a 
lateral tail vein. As the USPIO nanoparticles have a prolonged 
blood half-life, the SPIO nanoparticles were used the last 
to avoid any residual effect on the studies when performed 
with the Gd-DTPA. The parameters for T1 image was spin 
echo (SE) with repetition time (TR) 460 ms, echo time 
(TE) 9.0 ms in a matrix size of 512 × 512, for T1 weighted 
image was SE with TR/TE = 420 ms/9.0 ms in a matrix size 
of 256 × 256, for T2 image was fast spin echo (FSE) with 
TR/TE = 3000 ms/69.9 ms, echo train length (ET) = 17 ms 
in a matrix size of 256 × 256 and for T2 weighted image was 
gradient echo with TR/TE/ﬂ  ip angle = 340 ms/17 ms/ 30 in 
a matrix size of 512 × 512. In addition, a concentration of 
SPIO nanoparticles at 0.18 mmol Fe/kg was employed for 
in vivo studies, which roughly corresponds to a dose of 0.07 
Table 1 A comparison of T1 and T2 values of Gd-DTPA and the 
SPIO particle in water, which were measured using each pulse 
for refocusing in the multiecho sequence
Reagents T1 T 2
ddH2O 2117  ms  2039  ms
Gd-DTPA  603 ms  559 ms
SPION  408 ms  108 ms
Table 2 The relaxivities of Gd-DTPA and the SPIO nanoparticle 
at the same magnetic ﬁ  eld strength
Samples Magnetic  ﬁ  eld   r1  r2  r2/r1
 strength  (T)  L/mmol.sec–1 (L/mmol.sec–1) 
Gd-DTPA 0.3  11.86  12.98  1.09
SPION 0.3  19.79  87.69  4.43International Journal of Nanomedicine 2007:2(4) 809
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mmol Fe/kg assuming that the blood volume is 70 ml/kg b.w. 
in mammals. This dose results in increasing T2 shortening, 
which led to negative enhancement or “black-out” of the liver 
(Figure 5b). As a result, the SPIO nanoparticle was used for 
MRI detection of hepatoma nodules around 1mm in diameters 
in the liver of rats (Figure 5b). In Figure 6, HCC lesions in 
a rat liver showed low signal intensity on the T1-weighted 
SE (Figures 6a and 6c) and isointensive nodules on the T2-
weighted SE (Figures 6b and 6d). All the MRI ﬁ  ndings were 
further conﬁ  rmed by necropsy and histological examinations. 
The Gd-DTPA was used for comparative observation (Figures 
6e and 6f).
Discussion
Betaine is a liver-born S-adenosylmethionine (SAM) 
generator with active surface property. It has been known 
e d
20× 20× SPION Control
20× 20× SPION Control
a Iron concentration (mM)
0
10
20
50
60
70
80
90
100
110
120
control 5
%
 
C
e
l
l
 
v
i
a
b
i
l
i
t
y
40
30
SPION + SMMC-7721
SPION + HL7702
Gd-DTPA + SMMC7721
Gd-DTPA + HL7702
1 0.2
c b
Figure 3 Evaluation of the cytotoxicity of the SPIO nanoparticle both in vitro and in vivo. Two human hepatic celllines were employed for MTT assay (a). Prussian blue 
staining of the transfected cells showed the uptaking of the SPIO nanoparticles in the cytoplasm (b), and no staining was observed in the cytoplasm of the cells transfected 
with Gd-DTPA (c) and the no-transfected SMMC-7721 (d). In addition, hemolysis assay was carried out and no adverse effects on red blood cells regarding its number and 
shape 24h later following systemic administration of the nanoparticles (10mg/kg) in rats (e, the dilution of isolated RBCs was 1:200). Our results demonstrated that the 
prepared SPIO nanoparticle would be biocompatible.International Journal of Nanomedicine 2007:2(4) 810
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that betaine is involved in the reaction of methionine 
metabolism in mammalian liver and it is a promising 
alternative to expensive SAM agent in the treatment of 
liver dysfunction and other human maladies (Barak et al 
1996). Taking the advantage of betaine as a liver-born SAM 
generator with active surface property, we hypothesized 
that betaine modiﬁ  cation could change both the physical 
and biological properties of the nanoparticles and thereby 
would offer improvement of their biosafety proﬁ  les and 
pharmacokinetic properties.
There are two recent reports of non-polymer coated 
SPIO nanoparticles. The VSOP-C91 (Ferropharm, Teltow, 
Germany) coated with a citrate monomer is characterized by 
a favorable ratio of T2 relaxivity (r2) to T1 relaxivity (r1) in 
combination with a long blood pool half-life (Reimer et al 
1992; Chouly et al 1996). In another study, a SPIO nanopar-
ticle incorporated with (CH3)4N+ was investigated using a 
1.5 T clinical MR imager, in which signiﬁ  cant reduction of 
the background medium signal was found in the T2-weighted 
and the T2*-weighted sequence in the serum and whole 
blood (Taupitz et al 2002) in vitro. In our approach, the SPIO 
nanoparticles were stabilized by betaine monomer and were 
systematically investigated both in vitro and in vivo.
Kinetic studies of the liver MR contrast agents suggest that 
hydrophobic surface may enhance the uptake of the nanopar-
ticles by the liver, while hydrophilic coating and surface 
charges may inﬂ  uence their retention period in the circulation 
(Taupitz et al 2000; Schnorr et al 2002; Wagner et al 2002). In 
this study, we found that the betaine coated SPIO nanoparticle 
presented signiﬁ  cant reduction of the background signal in the 
T2-weighted sequence, which led to adequate performance in 
the detection of hepatoma nodules varied 1∼25 mm at a low 
Figure 4 The signal intensity alterations inﬂ  uenced by interactions between nanoparticles and water or whole blood were analyzed using different imaging sequences. The 
samples were diluted in water or human whole blood at different concentrations. The representative images of Figures 1a and 1b were acquired from T1 and T2 respectively. 
The T2 weighted MR signal intensity was affected by the ion concentrations of the two contrast agents (c). The nanoparticle in human whole blood ranged from 10−2 to 
10−5 M. Signiﬁ  cant decreasing of signal intensity at 10−3 M, especially in T2 weighted MR image, was observed (d).
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Figure 5 MR image and histological examination of hepatoma nodule in a rat model. Following administration of SPIO nanoparticles 45 min, MR images for the almost 
same axial slice of the liver on the T1-weighted SE (a) and on the T2-weighted SE (b) were performed. On the T2-weighted SE MR image, the enhancement of negative 
signals of liver and small nodules isointensive to liver was found. At necropsy 1h later after MRI, hepatoma nodules were found in the liver of rat (c). Hematoxylin staining of 
the resected parafﬁ  n specimen from the rat showed well-differentiated hepatoma cells (d), comparing with normal controls (e). The histological results conﬁ  rmed the MRI 
and necropsy ﬁ  ndings further.
Figure 6 MR images of hepatoma lesions in a rat liver. Following administration of 
SPIO nanoparticles 45 min and 24 hours later, the hepatoma nodules were shown 
low signal intensity on the T1-weighted SE (a and c), isointensive nodules were 
found on the T2-weighted SE (b and d). The Gd-DTPA was used as a control (e and 
f). To avoid any residual effect on the study, the SPIO nanoparticles were adminis-
trated 48 hours later following injection of the commercial Gd-DTPA.
Gd-DTPA T1 5 min  
e
Gd-DTPA T2 5 min 
f
SPION T1 45 min 
a
SPION T2 55 min 
b
SPION T2 24h 
d c
SPION  T2 24h 
dose. In addition, the nanoparticles fabricated in the water 
phase have additional advantages over those synthesized in the 
organic phase or those required additional polymer protection 
for stabilization. This could not only provide a more physi-
ological reaction background for the tagged biomolecules, but 
have distinct biodistribution and metabolic clearance proﬁ  le 
than the conventional polymer coated particles. Moreover, 
betaine modiﬁ  cation could improve the biosafety proﬁ  les of 
the SPIO nanoparticle and could be a promising SAM carrier 
for the treatment of some liver dysfunction.
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